Moderna Inc said on Thursday that its novel coronavirus vaccine candidate ‘mRNA-1273’ has been cleared by the US Food and Drug Administration (FDA) for phase 2 study. The phase 2 trial will involve some 600 participants and is expected to begin shortly as the drug maker scales up its efforts to combat the COVID-19 pandemic. On Wednesday, a team of Italy scientists claimed to have created the world's first coronavirus vaccine that can neutralise the SARS-CoV-2 virus in human cells. TimesNowNews
Friday, May 8, 2020
Moderna COVID-19 vaccine 'mRNA-1273' gets FDA approval for phase 2 trial
Moderna Inc said on Thursday that its novel coronavirus vaccine candidate ‘mRNA-1273’ has been cleared by the US Food and Drug Administration (FDA) for phase 2 study. The phase 2 trial will involve some 600 participants and is expected to begin shortly as the drug maker scales up its efforts to combat the COVID-19 pandemic. On Wednesday, a team of Italy scientists claimed to have created the world's first coronavirus vaccine that can neutralise the SARS-CoV-2 virus in human cells. TimesNowNews
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment